• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美沙酮治疗项目留存率的预测因素:信号检测分析

Predictors of retention in methadone programs: a signal detection analysis.

作者信息

Villafranca Steven W, McKellar John D, Trafton Jodie A, Humphreys Keith

机构信息

Center for Health Care Evaluation, Veterans Affairs Palo Alto Health Care System & Stanford University School of Medicine, CA, USA.

出版信息

Drug Alcohol Depend. 2006 Jul 27;83(3):218-24. doi: 10.1016/j.drugalcdep.2005.11.020. Epub 2005 Dec 27.

DOI:10.1016/j.drugalcdep.2005.11.020
PMID:16384657
Abstract

Retention in Opioid Agonist Therapy (OAT) is associated with reductions in substance use, HIV risk behavior, and criminal activities in opioid dependent patients. To improve the effectiveness of treatment for opioid dependence, it is important to identify predisposing characteristics and provider-related variables that predict retention in OAT. Participants include 258 veterans enrolled in 8 outpatient methadone/l-alpha-acetylmethadol (LAAM) treatment programs. Signal detection analysis was utilized to identify variables predictive of 1-year retention and to identify the optimal cut-offs for significant predictors. Provider-related variables play a vital role in predicting retention in OAT programs, as higher methadone dose (> or =59 mg/day) and greater treatment satisfaction were among the strongest predictors of retention at 1-year follow-up.

摘要

接受阿片类激动剂治疗(OAT)的留存率与阿片类药物依赖患者的物质使用减少、HIV风险行为降低以及犯罪活动减少相关。为提高阿片类药物依赖治疗的有效性,识别预测OAT留存率的易感特征和与提供者相关的变量非常重要。研究参与者包括258名参加8个门诊美沙酮/左旋-α-乙酰美沙醇(LAAM)治疗项目的退伍军人。采用信号检测分析来识别预测1年留存率的变量,并确定显著预测因素的最佳临界值。与提供者相关的变量在预测OAT项目的留存率方面起着至关重要的作用,因为较高的美沙酮剂量(≥59毫克/天)和更高的治疗满意度是1年随访时留存率最强的预测因素之一。

相似文献

1
Predictors of retention in methadone programs: a signal detection analysis.美沙酮治疗项目留存率的预测因素:信号检测分析
Drug Alcohol Depend. 2006 Jul 27;83(3):218-24. doi: 10.1016/j.drugalcdep.2005.11.020. Epub 2005 Dec 27.
2
The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.在直接观察治疗项目中,持续使用非法药物对接受HIV治疗的非法药物使用者美沙酮依从性的影响。
Drug Alcohol Depend. 2007 Jul 10;89(2-3):306-9. doi: 10.1016/j.drugalcdep.2007.02.007. Epub 2007 Mar 23.
3
Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use.左旋α-乙酰美沙多(LAAM)与美沙酮对比:治疗保持率与阿片类药物使用情况
Addiction. 2005 Aug;100(8):1131-9. doi: 10.1111/j.1360-0443.2005.01122.x.
4
Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.丁丙诺啡维持治疗和美沙酮维持治疗的海洛因成瘾患者12个月内的物质使用情况及生活质量
J Subst Abuse Treat. 2007 Jul;33(1):91-8. doi: 10.1016/j.jsat.2006.11.009. Epub 2007 Jan 16.
5
Levo-alpha-acetylmethadol (LAAM) versus methadone maintenance: 1-year treatment retention, outcomes and status.左旋-α-乙酰美沙醇(LAAM)与美沙酮维持治疗:1年治疗留存率、结局及状况
Addiction. 2007 Sep;102(9):1432-42. doi: 10.1111/j.1360-0443.2007.01935.x.
6
The impact of benzodiazepine use on methadone maintenance treatment outcomes.苯二氮䓬类药物的使用对美沙酮维持治疗效果的影响。
J Addict Dis. 2008;27(3):37-48. doi: 10.1080/10550880802122620.
7
Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems.阿片类药物替代治疗的不同组成部分可预测有或没有物质使用问题父母的患者的治疗结果。
J Stud Alcohol Drugs. 2007 Mar;68(2):165-72. doi: 10.15288/jsad.2007.68.165.
8
Summary of Veterans Administration Phase II cooperative study for LAAM and methadone.退伍军人管理局关于左-α-乙酰美沙酮(LAAM)和美沙酮的二期合作研究总结。
NIDA Res Monogr. 1976 Jul(8):94-102.
9
Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.多模式药物成瘾治疗:海洛因和可卡因依赖患者中美沙酮与丁丙诺啡的实地比较
J Subst Abuse Treat. 2006 Jul;31(1):3-7. doi: 10.1016/j.jsat.2006.03.007.
10
Predictors of patient retention in a newly established methadone maintenance treatment programme.新设立的美沙酮维持治疗项目中患者留存率的预测因素
Addiction. 1997 Oct;92(10):1353-60.

引用本文的文献

1
Retention of people who inject drugs enrolled in a 'medications for opioid use disorder' (MOUD) programme in Uganda.乌干达“阿片类物质使用障碍治疗药物”(MOUD)项目中,注射吸毒者的保留率。
Addict Sci Clin Pract. 2024 May 15;19(1):39. doi: 10.1186/s13722-024-00468-4.
2
Association of hospital-based substance use supports on emergency department revisits: a retrospective cohort study in Sudbury, Canada from 2018 to 2022.加拿大萨德伯里 2018 年至 2022 年的一项回顾性队列研究:基于医院的物质使用支持与急诊科复诊的关联。
Harm Reduct J. 2024 Mar 28;21(1):71. doi: 10.1186/s12954-024-00985-0.
3
Outcome in methadone maintenance treatment of immigrants from the former Union of Soviet Socialist Republics.
来自前苏联的移民接受美沙酮维持治疗的结果。
Harm Reduct J. 2024 Mar 1;21(1):55. doi: 10.1186/s12954-024-00970-7.
4
Retention and critical outcomes among new methadone maintenance patients following extended take-home reforms: a retrospective observational cohort study.延长带回家药物政策改革后新美沙酮维持治疗患者的留存率及关键结局:一项回顾性观察队列研究
Lancet Reg Health Am. 2023 Dec 4;28:100636. doi: 10.1016/j.lana.2023.100636. eCollection 2023 Dec.
5
Initiation and rapid titration of methadone and slow-release oral morphine (SROM) in an acute care, inpatient setting: a case series.在急性护理、住院环境中启动和快速滴定美沙酮和控释口服吗啡(SROM):病例系列。
Eur J Med Res. 2023 Dec 8;28(1):573. doi: 10.1186/s40001-023-01538-0.
6
The impact of benzodiazepine exposure on treatment retention in an open-access methadone program: A retrospective cohort study.苯二氮䓬类药物暴露对开放获取美沙酮治疗中治疗保留率的影响:一项回顾性队列研究。
Drug Alcohol Depend. 2022 Dec 1;241:109707. doi: 10.1016/j.drugalcdep.2022.109707. Epub 2022 Nov 19.
7
Community trial evaluating the integration of Indigenous healing practices and a harm reduction approach with principles of seeking safety in an Indigenous residential treatment program in northern Ontario.安大略省北部的一个原住民住院治疗项目中,采用了评估将原住民治疗实践与减少伤害方法与寻求安全原则相融合的社区试验。
BMC Health Serv Res. 2022 Aug 16;22(1):1045. doi: 10.1186/s12913-022-08406-3.
8
Polysubstance Use Among Patients Treated With Buprenorphine From a National Urine Drug Test Database.从全国尿液药物检测数据库看丁丙诺啡治疗患者的多药物使用情况。
JAMA Netw Open. 2021 Sep 1;4(9):e2123019. doi: 10.1001/jamanetworkopen.2021.23019.
9
The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting.在加拿大环境下,阿片类激动剂治疗满意度与芬太尼暴露之间的关系。
Addict Sci Clin Pract. 2021 Apr 28;16(1):26. doi: 10.1186/s13722-021-00234-w.
10
Retention in the Austrian opioid agonist treatment system: a national prospective cohort study.奥地利阿片类激动剂治疗系统中的保留率:一项全国前瞻性队列研究。
Harm Reduct J. 2021 Feb 24;18(1):25. doi: 10.1186/s12954-021-00473-9.